India Orders Sun Pharma to Halt Eye-Care Drug Production Over Quality Lapses
- Published:
- First detected:
Insights by Echo AI
Indian drug regulators have directed Sun Pharmaceutical Industries to cease manufacturing, selling, and distributing ophthalmic products from its Assam facility due to failures in its quality management system. The move follows recent scrutiny of India's drug quality standards, particularly after locally made cough syrups were linked to child deaths in India and other countries.
Source coverage
7
records merged
6
4 unique
0
0 unique
1
1 unique
7 Sources
Sun Pharma ordered to halt eye drug production at Assam plant over qua...
India orders Sun Pharma to halt eye-care drug production at Assam plan...
India orders Sun Pharma to halt eye-care drug production at plant afte...
Unlock Echo Intelligence
Move beyond the public feed. Monitor breaking stories across Telegram, X, and the web — with earlier visibility, clearer context, and complete control over your sources.
- Monitor Telegram, X, and web in one place
- Add any source, from niche channels to global outlets
- Build custom feeds around events, regions, entities, or keywords
- Merge duplicate coverage into one clear, source-transparent story
- Auto-translate summaries and full articles
- Search past coverage and use AI-powered editorial tools
